Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avoiding Anticoagulation After IntraCerebral Haemorrhage

NCT03243175 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT03243175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03243175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avoiding Anticoagulation After IntraCerebral Haemorrhage
Lead sponsor
University Hospital, Lille
Phase
Phase 3
Overall status
Recruiting
Start date
January 17, 2019
Completion date
December 31, 2029
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, intracerebral hemorrhage, microhaemorrhage